McClellan Outlines Vision For Device User Fees, Third-Party Inspections
This article was originally published in The Gray Sheet
Executive Summary
Incoming FDA commissioner Mark McClellan, MD/PhD, is pledging to hold the agency to premarket review performance goals mandated under the "Medical Device User Fee and Modernization Act" if the bill becomes law
You may also be interested in...
FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest
A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator
FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest
A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator
Plano Contact Lens Warning Indicates Continued FDA Regulation As Devices
An FDA warning on the potential health risks of non-corrective (plano), decorative contact lenses signals that the products are unlikely to be regulated as cosmetics, as at least one manufacturer had hoped